Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
- Link:
- Autor/in:
- Erscheinungsjahr:
- 2009
- Medientyp:
- Text
- Lizenz:
-
- info:eu-repo/semantics/restrictedAccess
- Quellsystem:
- Forschungsinformationssystem des UKE
Interne Metadaten
- Quelldatensatz
- oai:pure.atira.dk:publications/59b5fbd2-f3c4-4074-8b67-85b19a682bd6